No description available.

No description available.

<p> The work describes the preparation and properties of some novel dibenzylideneacetone complexes of palladium and platinum. The structure and bonding in these complexes is discussed in view of their infrared and nuclear magnetic resonance spectra. The cyclotrimerization of acetylenes by zero-valent nickel complexes is discussed and the synthesis of a new cyclobutadiene-platinum complex is reported.</p> / Thesis / Master of Science (MSc)

Doctor of Philosophy (PhD) / The toxicity of platinum anticancer drugs presents a major obstacle in the effective treatment of tumours. Much of the toxicity stems from a lack of specificity of the drugs for the sites at which they are able to exert maximum anticancer activity. An improved understanding of the behaviour of the drugs in the tumour environment may assist in the rational design of future platinum anticancer agents with enhanced specificity and reduced toxicity. In the work presented herein, the specificity of two classes of platinum anticancer agents was assessed (platinum(IV) cisplatin analogues and platinum(II) anthraquinone complexes). The interaction of the platinum(IV) agents with DNA, believed to be their main cellular target, was examined using XANES spectroscopy. This experiment was designed to assess the ability of the drugs to interact with DNA and thus exert their anticancer activity. It was shown that the platinum(IV) complexes were not reduced by DNA during 48 hr incubation. It was not possible to conclusively determine whether the interaction of the complexes with DNA was direct or platinum(II) catalysed, or whether interaction had occurred at all. The distribution of platinum(II) anthraquinone complexes and their corresponding anthraquinone ligands in tumour cells (A2780 ovarian and DLD-1 colon cancer cell lines) was investigated. The cytotoxicity of the compounds in DLD-1 cells was also assessed. It was found that the compounds were efficiently taken up into the cells and entered the lysosomal compartments almost exclusively. This suggested that the cytotoxicity of the drugs was caused by lysosomal disruption, or that the platinum complexes were degraded, leaving a platinum species to enter the cell nuclei and interact with DNA. Alternatively, the complexes may bind to proteins and transport into the nuclei of the cells, though with their fluorescence quenched by the protein. The penetration and distribution of platinum(IV) complexes was assessed in DLD-1 multicellular tumour spheroids (established models of solid tumours) using a number of synchrotron techniques, including micro-tomography, micro-SRIXE, and micro-XANES. The complexes were found to be capable of penetrating throughout the entire volume of the spheroids. Micro-XANES indicated that in central and peripheral spheroidal regions, bound platinum species were present largely as platinum(II).

No description available.

Doctor of Philosophy (PhD) / The toxicity of platinum anticancer drugs presents a major obstacle in the effective treatment of tumours. Much of the toxicity stems from a lack of specificity of the drugs for the sites at which they are able to exert maximum anticancer activity. An improved understanding of the behaviour of the drugs in the tumour environment may assist in the rational design of future platinum anticancer agents with enhanced specificity and reduced toxicity. In the work presented herein, the specificity of two classes of platinum anticancer agents was assessed (platinum(IV) cisplatin analogues and platinum(II) anthraquinone complexes). The interaction of the platinum(IV) agents with DNA, believed to be their main cellular target, was examined using XANES spectroscopy. This experiment was designed to assess the ability of the drugs to interact with DNA and thus exert their anticancer activity. It was shown that the platinum(IV) complexes were not reduced by DNA during 48 hr incubation. It was not possible to conclusively determine whether the interaction of the complexes with DNA was direct or platinum(II) catalysed, or whether interaction had occurred at all. The distribution of platinum(II) anthraquinone complexes and their corresponding anthraquinone ligands in tumour cells (A2780 ovarian and DLD-1 colon cancer cell lines) was investigated. The cytotoxicity of the compounds in DLD-1 cells was also assessed. It was found that the compounds were efficiently taken up into the cells and entered the lysosomal compartments almost exclusively. This suggested that the cytotoxicity of the drugs was caused by lysosomal disruption, or that the platinum complexes were degraded, leaving a platinum species to enter the cell nuclei and interact with DNA. Alternatively, the complexes may bind to proteins and transport into the nuclei of the cells, though with their fluorescence quenched by the protein. The penetration and distribution of platinum(IV) complexes was assessed in DLD-1 multicellular tumour spheroids (established models of solid tumours) using a number of synchrotron techniques, including micro-tomography, micro-SRIXE, and micro-XANES. The complexes were found to be capable of penetrating throughout the entire volume of the spheroids. Micro-XANES indicated that in central and peripheral spheroidal regions, bound platinum species were present largely as platinum(II).

Thesis (MSc)--Stellenbosch University, 2013. / ENGLISH ABSTRACT: The high-resolution 195Pt NMR signals (128.8 MHz) of most of the octahedral mixed-ligand Pt(IV) complexes in the series [PtCl6-n(OH)n]2-, n = 0-6, have been recorded in aqueous solutions at 293 K. These signals show characteristic 35/37Cl isotope-induced fine structure that results from the presence of several isotopologues in samples with a natural chlorine isotope distribution; each 37Cl isotope incorporated into the Pt coordination sphere of one of these complexes affords a fixed upfield (low frequency) isotope shift of between 0.17 and 0.22 ppm, depending on the particular complex. This assignment is confirmed by the excellent agreement between the natural abundances of the various isotopologues and the relative contributions of the corresponding signals to the overall area of the experimental spectrum of the particular isotoplogue set, obtained by a non-linear least-squares line fitting procedure. These results confirm that the 195Pt magnetic shielding in isotopomers differing only in the combination of the two chlorine isotopes coordinated in sites trans to hydroxido-ligands are indistinguishable under these experimental conditions, unlike those of similar isotopomers in the related series of aqua-complexes [PtCln(H2O)6-n]4-n, n = 3-5, as reported by Koch and co-workers. Moreover, the order of 195Pt shielding for the members of all stereoisomer pairs in the series of hydroxido-complexes is the reverse of that reported for the corresponding pairs in the aqua-series. These and other observations are interpreted qualitatively in terms of the relative strengths of the trans-influences of aqua-, hydroxido- and chlorido-ligands and the effect of these on bond displacements in these complexes. The 195Pt NMR spectra of especially the complexes cis-[PtCl2(OH)4]2- and [PtCl(OH)5]2- show remarkable fine structure in a ca. 45 % 18O-enriched aqueous solution; apart from additional signals resulting from 18O-containing isotopologues, the resonance signals of isotopomers differing in the combination of 16/18O isotopes in sites trans to chlorido-ligands are partially resolved. The effect of temperature on the 35/37Cl isotope-induced fine structure in the 195Pt signals of [PtCl6]2- and [PtCl(OH)5]2- was investigated in the range 283-308 K; some interesting differences are observed. 195Pt relaxation time measurements for [PtCl6]2- in this temperature range reveal that line-broadening is at least partially responsible for the loss of resolution between the signals of isotopologues of this complex as the temperature is increased, possibly due to the spin-rotation relaxation mechanism. The temperature coefficient of 195Pt shielding and the magnitude of isotope shifts in the spectra of the complexes in this series show interesting correlations with the 195Pt shielding itself; an interpretation of these observations is presented. / AFRIKAANSE OPSOMMING: Die hoëresolusie 195Pt NMR seine (128.8 MHz) van die oktaëdriese gemengde-ligand Pt(IV) komplekse in die reeks [PtCl6-n(OH)n]2- is waargeneem in waterige oplossing by ʼn temperatuur van 293 K. Hierdie seine toon ʼn karakteristieke 35/37Cl isotoop-geïnduseerde fynstruktuur as gevolg van die teenwoordigheid van verskeie isotopoloë in monsters met ʼn natuurlike chloor isotoopverspreiding. Die verplasing van ʼn 35Cl isotoop deur ʼn 37Cl isotoop in die Pt koördinasiesfeer van hierdie komplekse lei tot ʼn laefrekwensie isotoopverskuiwing van die 195Pt resonansiesein van tussen 0.17 en 0.22 ppm, afhangend van die spesifieke kompleks. Die toekenning van resonansieseine in hierdie spektra word ondersteun deur die goeie ooreenstemming tussen die berekende natuurlike verspreiding van isotopoloë en die persentasie area bydrae van die ooreenstemmende pieke tot die area van volledige stel seine van die chemiese spesie, soos bepaal deur ʼn nie-linieêre kleinste-kwadrate passingsmetode. Hierdie resultate bevestig dat vir isotopomere waarvan slegs die kombinasie van chloorisotope wat in posisies trans tot hidroksido-ligande gekoördineer is ʼn ononderskeibare 195Pt magnetiese skerming waargeneem word, m.a.w. ʼn enkele resonansiesein word vir hierdie isotopomere gemeet, anders as gerapporteer deur Koch en medewerkers vir die verwante aqua-komplekse [PtCln(H2O)6-n]4-n waar n = 3-5. Verder is die order van 195Pt magnetiese skerming vir stereoisomere in hierdie hidroksido-komplekse in elke stereoisomer paar die teenoorgestelde van dit waargeneem vir die ooreenstemmende aqua-komplekse. Hierdie waarnemings word kwalitatief geïnterpreteer in terme van die verskillende trans-invloede van die chlorido-, aqua- en hidroksido-ligande en die effekte daarvan op bindingslengtes in die komplekse. In ʼn ongeveer 45 % 18O-verrykte monster toon die 195Pt seine van veral die komplekse cis-[PtCl2(OH)4]2- en [PtCl(OH)5]2- uitsonderlike fynstruktuur vanweë die addisionele seine van 18O-bevattende isotopoloë en die parsiële resolusie van die seine van isotopomere wat verskil in die kombinasie van 16/18O isotope wat trans tot chlorido-ligande gekoördineer is. ʼn Studie is gemaak van die uitwerking van temperatuur op die 35/37Cl isotoop-geïnduseerde fynstruktuur in die 195Pt seine van die komplekse [PtCl6]2- en [PtCl(OH)5]2- in die gebied 283-308 K; interessante verskille is waargeneem. 195Pt magnetiese relaksasietyd metings vir die kompleks [PtCl6]2- in waterige oplossing in hierdie temperatuurgebied toon dat verbreeding van resonansieseine ten minste gedeeltelik verantwoordelik is vir die waargenome verlies aan resolusie tussen die seine van isotopoloë namate die temperatuur styg; die verbreeding van seine kan waarskynlik aan die spin-rotasie relaksasiemeganisme toegeskryf word. Die temperatuurkoëffisiënt van 195Pt magnetiese skerming en die grootheid van isotoopverskuiwings in die spektra van die hidroksido-komplekse in hierdie reeks toon interessante korrelasies tot die 195Pt magnetiese skerming; ʼn interpretasie van hierdie waarnemings word voorgestel.

Foram determinadas as estruturas de três complexos de Platina, dois complexos de estanho e um ligante orgânico. AS intensidades das reflexões foram medidas com umdifratômetro CAD-4. As estruturas foram resolvidas por métodos diretos ou pela função de Patterson e refinadas por mínimos quadrados. Bis (fenilsulfonil) etano, C14H14(SO2)2, foi obtido durante as tentativas de sintetizar ligantes para serem usados na complexação com diversos organo-estânicos, o cristal pertence ao sistema moniclínico, P21/n, a= 8,495(3), b= 10,159(1), c= 9,072(1)&#197, &#946= 116,23(2) &#176, V= 702,3(3) &#1973, Z= 2, dcalc= 1,467g.cm-3. Cis-dicloro[meso-1,2-bis(n-propilsulfinil)etano]platina(II), PtCl2. (PrSO)2C2H4, o cristal pertence ao sistema ortorrômbico, P212121, a= 7,360(2), b= 9,793(2), c= 19,369(2)&#197, V= 1396,1(4)&#1973, Z= 4, dcalc= 2,25g.cm-3. Trans-diclorol[(trietilfosfina) (2-metilsulfinil)piridina)]platina(II), Et3PPtCl 2.PySOMe, o cristal pertence ao sistema monoclínico, P21/c, a= 8,067(3), b= 8,5184(9), c= 25,592(3)&#197, &#946= 92,000(9)&#176, V= 1757,6(7)&#1973, Z= 4, dcalç= 1,98g.cm-3. Trans-dicloro [(trietilfosfina)(2-n-propilsulfinil)piridina)]platina(II), Et3PPtCl2.PySOPr, o cristal pertence ao sistema triclínico, P-1, a= 8,254(3), b= 8,377(4), c= 14,531(4)&#197, &#945= 87,14(3), &#946= 82,83(3), &#933= 84,10(3)&#176, V= 991,0(7)&#1973, Z= 2, dcalc= 1,78g.cm-3. Mer-tricloro [(2-metilsulfinil)benzotiazol)]metilestanho(IV), MeSnCl3.BtSOMe)2, o cristal pertence ao sistema monoclínico, C2/c, a= 20,083(2), b= 17,406(1), c= 14,415(2)&#197, &#946= 108,06(3), V= 4790,5(8)&#1973, Z= 8, dcalc= 1,78g.cm-3. Hidroxi cloreto de difenil estanho (IV) + mesobis (fenilsulfinil)metano, SnClOHPh2 + Ph2(SO) 2CH2, o cristal pertence ao sistema monoclínico, P21/c, a= 10,540(3), b= 9,743(1), c= 24,099(7)&#197, &#946= 92,95(2), V= 2471(1)&#1973, Z= 4, dcalç= 1,58g.cm-3 / The structures of three platinum complexes, two organotin compounds and organic ligand were determined. The reflection intensities were measured with a CAD-4 automatic diffractometer. The structures were solved by direct methods or the Patterson function and were refined by least squares method. Bis (phenylsulfonyl)ethane, C14H14(SO2)2, was obtained among attempts to synthesize ligands to be used for complexation with several organotins, the crystal belongs to the monoclinic system, P21/n, a= 8,495(3), b= 10,159(1), c= 9,072(1)&#197, &#946= 116,23(2) &#176, V= 702,3(3) &#1973, Z= 2, dcalc= 1,467g.cm-3. Cis-dichloro [ meso 1,2-bis(n-propylsulphinyl)ethane]platinum(II), PtCl2. (PrSO)2C2H4 the crystal belongs to the orthorhombic system, P212121, a= 7,360(2), b= 9,793(2), c= 19,369(2)&#197, V= 1396,1(4)&#1973, Z= 4, dcalc= 2,25g.cm-3. Trans-dichloro [(triethylphosphine) (2-methylsulphinyl)pyridine)]platinum(II), Et3PPtCl 2.PySOMe, the crystal belongs to the monoclinic system, P21/c, a= 8,067(3), b= 8,5184(9), c= 25,592(3)&#197, &#946= 92,000(9)&#176, V= 1757,6(7)&#1973, Z= 4, dcalç= 1,98g.cm-3. Trans-dichloro [(triethylphosphine) (2-npropylsulphinyl) pyridine)]platinum(II), Et3PPtCl2.PySOPr, the crystal belongs to the orthorhombic system, P-1, a= 8,254(3), b= 8,377(4), c= 14,531(4)&#197, &#945= 87,14(3), &#946= 82,83(3), &#933= 84,10(3)&#176, V= 991,0(7)&#1973, Z= 2, dcalc= 1,78g.cm-3. Mer-trichloro[(2-methylsulphinyl)benzothiazole)]methyltin(IV), MeSnCl3.BtSOMe)2 the crystal belongs to the monoclinic system, C2/c, a= 20,083(2), b= 17,406(1), c= 14,415(2)&#197, &#946= 108,06(3), V= 4790,5(8)&#1973, Z= 8, dcalc= 1,78g.cm-3. Hidroxe chloride diphenyl tin (IV) + mesobis (phenylsulphinyl)methane, SnClOHPh2 + Ph2(SO) 2CH2 the crystal belongs to the monoclinic system, P21/c, a= 10,540(3), b= 9,743(1), c= 24,099(7)&#197, &#946= 92,95(2), V= 2471(1)&#1973, Z= 4, dcalç= 1,58g.cm-3

Desde a descoberta da cisplatina várias tentativas têm sido feitas com o objetivo de desenvolver novos quimioterápicos com menor toxicidade e efeitos colaterais melhorados para tratar o câncer. Complexos de coordenação com metais de transição variados vêm sendo estudados buscando melhoras na biodisponibilidade, seletividade e efeitos adversos. Neste sentido, o presente trabalho consiste na síntese e caracterização estrutural de complexos de PdII e PtII com ligantes derivados de tiossemicarbazidas contendo o grupo fluoróforo pireno visando a obtenção de potenciais agentes antitumorais. Os agentes quelantes foram preparados a partir de reações de condensação entre o pirenocarboxaldeído e a tiossemicarbazida desejada resultando em compostos 1-pirenocarboxaldeído-N(3)-R-tiossemicarbazona, H2PrR, onde R = etil ou ciclohexil, Pr = pireno. A partir dos ligantes H2PrR foram realizadas as reações de complexação com os íons metálicos PdII e PtII, sendo possível obter duas classes de complexos com diferentes características: complexos monoméricos contendo ligantes clorido e trifenilfosfano do tipo [MCl(PPh3)(HPrR)] e complexos tetraméricos do tipo [M4(&mu;-S-PrR-&kappa;3-C,N,S)4], onde M = PdII ou PtII, R = etil ou ciclohexil. Nas duas primeiras séries, o grupo R foi modificado por etil e ciclohexil para investigar a correlação entre lipoficilidade e atividade antiproliferativa, enquanto que o grupamento pireno foi incluído pensando que um maior número de unidades aromáticas possivelmente melhoraria a intercalação com o DNA e/ou ser utilizado como um marcador celular. A caracterização dos complexos envolveu técnicas como: análise elementar, espectroscopia na região do infravermelho e do UV-Vis, condutimetria, ressonância magnética nuclear (1H e 13C RMN) e difração de raios X em monocristal. As análises mostraram que os agentes complexantes podem atuar em diferentes modos coordenação tanto com relação à denticidade quanto à carga. A atividade antiproliferativa dos novos compostos de PdII e PtII foi determinada, sendo que vários deles apresentaram IC50 promissores contra células de câncer de ovário e, em muitos casos, as atividades observadas foram melhores do que a da cisplatina. Os dados obtidos indicam efeitos diferentes nos resultados de atividade biológica para os centros metálicos (Pd vs Pt) e ligantes utilizados (Etil vs Ciclohexil). Estudos de captação e distribuição celular mostraram que o complexo [PdCl(PPh3)(HPrCh)] atinge o núcleo celular. Com o intuito de verificar possíveis alvos biológicos, testes de interação com o DNA, ciclo celular e inibição da enzima Top IB foram realizados para os compostos. Os resultados do ciclo celular, mostraram uma maior inibição nos estádios S e G2/M para os complexos do tipo [PdCl(PPh3)(HPrR)]. Diante dos resultados obtidos, verificou-se que a Top IB é um dos alvos moleculares para os complexos do tipo [MCl(PPh3)(HPrR)], um mecanismo diferente da cisplatina. Estes resultados preliminares são bastante promissores e mostram que alguns dos complexos estudados neste trabalho apresentam-se como potenciais agentes para serem usados na terapia do câncer em combinação com os demais fármacos em uso clínico. / Since the discovery of cisplatin, many attepemts have been made to prepare new drugs with less cytotoxicity and side effects. Coordination complexes based on a variety of transition metals have been developed in the search for improved bioavailability, selectivity and reduced adverse side-effects. This work consists on the synthesis and structural characterization of PdII and PtII complexes with chelating compounds derived from thiosemicarbazides containing the pyrene fluorophore group aiming to obtain potential antitumor compounds. The chelating agents were prepared from condensation reactions between the pyrenocarboxaldehyde and the desired thiosemicarbazide resulting in 1-pyrenocarboxaldehyde-N (3) -R-thiosemicarbazone compounds, H2PrR, where R = ethyl or cyclohexyl. Complexation reactions with the metal ions PdII and PtII were carried out with the H2PrR ligands. It was possible to obtain two main classes of complexes with different characteristics: i) monomeric complexes containing chlorido and triphenylphosphane ligands of the type [MCl(PPh3)(HPrR)] and (ii) tetramer complexes of the type [{M(PrR)}4], where M = PdII or PtII and R = etyl ou cyclohexyl. In both series the R group was modified by ethyl and cyclohexyl in order to investigate the correlation between lipophilicity and antiproliferative activity, while the pyrene group was attached to the ligands with the belief that a higher number of aromatic units would improve DNA intercalation and/or to be used as an intracellular probe. The characterization of the complexes involved techniques such as: elemental analysis, infrared and UV-Vis spectroscopy, conductimetry, nuclear magnetic resonance (1H and 13C NMR) and single crystal X-ray diffraction. The antiproliferative activity of the novel PdII and PtII compounds have been determined, several of them showed promising IC50 against ovarian cancer cells, and in many cases the observed activities are better than that of cisplatin. The data obtained indicate different effects for the metal centers (Pd vs Pt) and the ligands used (ethyl vs cyclohexyl). Uptake and cellular distribution studies proved that the palladium complex [PdCl(PPh3)(HPrCh)] achieved the cell nucleus. In order to verify possible biological targets, interaction with DNA, cell cycle and inhibition experiments of the topoisomerase IB (Top IB) enzyme were performed for some compounds. Cell cycle results showed an inhibition at the S and G2/M stages for the complexes [PdCl(PPh3)(HPrR)]. Overall, the results indicated the Top IB enzyme as one of the targets of the complexes. These preliminary results are quite promising and show that some of the complexes studied here can be used in cancer therapy in combination with other anticancer drugs.

The reaction of potassiumtetrachloroplatinate with 2-aminothiophenol, yielded a dark blue solid product. This work is about the characterization of this dark blue solid and the investigation of its binding interaction to DNA and enzyme activity. The blue solid product or the &ldquo / blue complex&rdquo / (as we called it in this work) is soluble in acetone, acetonitrile and DMSO yielding a blue solution. It is stable in solution and has a very strong absorption band at 724 nm. The product is paramagnetic and displays one kind of platinum in XPS (platinum binding energies were obtained at 71.1 and 74.6 eV, respectively). The elemental (C, H, N, S, Pt) analysis indicated that the platinum to ligand (2- aminothiophenolate) mole ratio is 1:2. The interpretation of the data collected from elemental analysis and ESR, XPS, NMR, CV measurements leads to conclude that the blue complex prepared in this work is a new platinum blues. This is the first example of platinum blues, in which the bridging ligand is a nitrogen and sulfur donor one. The proposed structure can be visualized as a dimer of binuclear head-tohead isomer of the green product, with C2h symmetry. The band at 724 nm is assigned to an allowed electronic transition from a metal-5dz orbitals based MO to metal-6pz orbitals based MO in tetranuclear core. In order to determine the binding mode of the blue complex to ct-DNA, electronic absorption spectroscopy is employed and hyperchromism about 17.5 percent is observed, which indicates a weak binding of the blue complex to DNA, such as electrostatic interaction of metal ions or H-bonding through the hydroxyl group of the complex. Voltammetric titration carried out in solution suggested the preferential stabilization of Pt(III) to Pt(II) on binding to DNA. The blue complex inhibits the GSTs activity between 45-200 micromolar, in sheep liver GST enzyme. The GST enzymes causes drug resistance, therefore inhibition of this enzyme suggests that this complex can be used in combined chemotherapy.